Hagop M. Kantarjian - Concepedia

Author

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Also Known As

Hagop Kantarjian, Hagop M. Kantarjian

Publications

896

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center

About

Hagop M. Kantarjian is an author at The University of Texas MD Anderson Cancer Center specializing in hematology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	471
2	Pathology	7	7	471
3	Health Sciences	2	2	95
4	Immunology	2	2	178
5	Cell Biology	1	1	44

Hagop M. Kantarjian

Publications

792

Citations

H-Index

Page 1

	Year	Citations
Primary refractory and relapsed adult acute lymphoblastic leukemia Deborah A. Thomas, Hagop M. Kantarjian, Terry L. Smith, Cancer	1999	196
Leukapheresis Reduces Early Mortality in Patients with Acute Myeloid Leukemia with High White Cell Counts But Does Not Improve Long Term Survival Francis J. Giles, Yu Shen, Hagop M. Kantarjian, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaHematology	2001	145
Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia Stefan Faderl, Hagop M. Kantarjian, Deborah A. Thomas, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyChromatinOncologyMedicinePhiladelphia Chromosome	2000	140
Untreated Aggressive Mantle Cell Lymphoma: Results with Intensive Chemotherapy without Stem Cell Transplant in Elderly Patients Jorge Romaguera, Issa F. Khouri, Hagop M. Kantarjian, Leukemia & lymphoma/Leukemia and lymphoma Elderly PatientsPathologyPharmacotherapyMetronomic ChemotherapyHematological Malignancy	2000	68
Chronic myelogenous leukaemia with p185<i><sup>BCR/ABL</sup></i> expression: characteristics and clinical significance Farhad Ravandi, Jörge E. Cortes, Maher Albitar, British Journal of Haematology	1999	63
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia Samer Suki, Hagop M. Kantarjian, Varsha Gandhi, Cancer	1993	48
Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside Hagop M. Kantarjian, Ronald S. Walters, Michael J. Keating, Cancer Mixed-phenotype Acute LeukemiaPathologyChronic Myelogenous LeukemiaPharmacotherapyMyeloid Neoplasia	1988	44
Detection of Subgroups of Chronic B-Cell Leukemias by FMC7 Monoclonal Antibody Yang O. Huh, William Pugh, Hagop M. Kantarjian, American Journal of Clinical Pathology Mixed-phenotype Acute LeukemiaImmunologyPathologyImmunophenotypingImmunotherapy	1994	33
Significance of cytogenetic abnormalities in patients with polycythemia vera Matjaž Sever, Alfonso Quintás‐Cardama, Sherry Pierce, Leukemia & lymphoma/Leukemia and lymphoma CytogeneticsMixed-phenotype Acute LeukemiaPathologyEpigeneticsMyeloid Neoplasia	2013	27
Results of Therapy with Interferon Alpha and Cyclic Combination Chemotherapy in Patients with Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Early Chronic Phase Francis J. Giles, Hagop M. Kantarjian, Susan O’Brien, Leukemia & lymphoma/Leukemia and lymphoma Early Chronic PhaseHematological MalignancyOncologyCyclic Combination TherapyCyclic Intensive Chemotherapy	2001	14

Page 1